Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016)
Clinical trial NCT03537274 · COMPLETED
Trial details
- NCT number
- NCT03537274
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-08-05
- Primary completion
- 1999-07-23
- Enrollment
- 1224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.